Posts tagged: active
Active Ingredient in Viagra Shrunk Disfiguring Growths in Kids
By Randy Dotinga HealthDay Reporter WEDNESDAY, Jan. 25 (HealthDay News) -- A new preliminary report suggests that the active ingredient in Viagra, sildenafil, could reduce the size of large growths that can disfigure the bodies of children. The findings could point to ...
Lifelong Active Brains Have Fewer Deposits Of Alzheimer’s Protein
A new study using PET scans to to examine the brains of healthy older people finds those who have been mentally stimulated all their lives, doing things like reading, writing, and playing games and puzzles, have fewer deposits of beta-amyloid, a destructive protein that is a hallmark of ...
Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype
A sedentary lifestyle is associated with greater cerebral amyloid deposition, which is characteristic of Alzheimers disease (AD), among cognitively normal individuals with the ε4 allele of the apolipoprotein E (APOE) gene, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.
APOE ε4 Genotype People Who Are Physically Active Have Lower Alzheimer’s Risk
A report published Online First in the Archives of Neurology, one of the JAMA/Archives journals, found that a sedentary lifestyle is linked to greater cerebral amyloid deposition, characteristic of Alzheimer's disease (AD), amongst cognitively normal individuals with the ε4 allele of the apolipoprotein E (APOE) gene. The background information ...
Physically Active Kids Appear To Do Better In Class
A systematic review of published data reported in the January issue of the Archives of Pediatrics & Adolescent Medicine finds there may be a positive link between physical activity and academic performance of children in school: the ones who are more physically active seem to do better in ...
MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost
In a bid to catalyse malaria and neglected disease drug discovery, MMV and SCYNEXIS, Inc. have assembled a Malaria Box of 400 carefully selected commercially available compounds with antimalarial activity and will provide it to researchers at no cost. All 400 compounds in the Malaria Box have ...
Novel Experimental Agent Is Highly Active In Chronic Lymphocytic Leukemia Patients, Interim Study Shows
An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, called PCI-32765, is the first drug designed to target Bruton's tyrosine ...
PCI-32765 is highly active and well tolerated in patients with CLL
An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy.
Novel experimental agent is highly active in CLL patients, interim study shows
An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, called PCI-32765, is the first drug designed to target Bruton's tyrosine ...
Novel experimental agent is highly active in CLL patients, interim study shows
COLUMBUS, Ohio An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, called PCI-32765, is the first drug ...
Novel experimental agent is highly active in CLL patients, interim study shows
(Ohio State University Medical Center) An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent is the first drug designed to target ...